Pretreatment Serum Testosterone Level as a Predictive Factor of Pathological Stage in Localized Prostate Cancer Patients Treated with Radical Prostatectomy
- 31 March 2005
- journal article
- clinical trial
- Published by Elsevier in European Urology
- Vol. 47 (3) , 308-312
- https://doi.org/10.1016/j.eururo.2004.11.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical ProstatectomyJournal of Urology, 2003
- Association between prostate cancer and serum testosterone levelsThe Prostate, 2002
- CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTSJournal of Urology, 2002
- High‐grade prostate cancer is associated with low serum testosterone levelsThe Prostate, 2001
- IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?Journal of Urology, 2000
- INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELSJournal of Urology, 1998
- Prognostic Factors in Patients With Metastatic (Stage D2) Prostate Cancer: Experience from the Scandinavian Prostatic Cancer Group Study-2Journal of Urology, 1997
- Prospective Study of Sex Hormone Levels and Risk of Prostate CancerJNCI Journal of the National Cancer Institute, 1996
- The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentrationUrology, 1995
- Effects of prostatectomy on testicular androgenesis and serum levels of gonadotropins in mature albino ratsThe Prostate, 1995